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Abstract
Background: Self-rated health (SRH) measures with different wording and reference points are often used as 
equivalent health indicators in public health surveys estimating health outcomes such as healthy life expectancies and 
mortality for older adults. Whilst the robust relationship between SRH and mortality is well established, it is not known 
how comparable different SRH items are in their relationship to mortality over time. We used a dynamic evaluation 
model to investigate the sensitivity of time-varying SRH measures with different reference points to predict mortality in 
older adults over time.
Methods: We used seven waves of data from the Australian Longitudinal Study of Ageing (1992 to 2004; N = 1733, 
52.6% males). Cox regression analysis was used to evaluate the relationship between three time-varying SRH measures 
(global, age-comparative and self-comparative reference point) with mortality in older adults (65+ years).
Results: After accounting for other mortality risk factors, poor global SRH ratings increased mortality risk by 2.83 times 
compared to excellent ratings. In contrast, the mortality relationship with age-comparative and self-comparative SRH 
was moderated by age, revealing that these comparative SRH measures did not independently predict mortality for 
adults over 75 years of age in adjusted models.
Conclusions: We found that a global measure of SRH not referenced to age or self is the best predictor of mortality, 
and is the most reliable measure of self-perceived health for longitudinal research and population health estimates of 
healthy life expectancy in older adults. Findings emphasize that the SRH measures are not equivalent measures of 
health status.
Background
Self-rated health (SRH) is a widely used measure for
health status in public health and epidemiological
research due to strong associations with other subjective
and objective measures of well-being, health outcomes
and mortality [e.g. [1]]. The multidimensional concept of
h e a l t h  t h a t  i s  e n ca ps u l a t ed  wi t h i n  a  s i n g l e  g l o ba l  S RH
r e s p o n s e  i s  c o n s i d e r e d  b y  W o r l d  H e a l t h  O r g a n i s a t i o n
(WHO[2]) and the Euro-REVES 2 [3] project to be one of
the best indicators of health at the individual and popula-
tion level. Both of these organisations have extensively
investigated the relationship between global SRH and
health outcomes and recommended the measure to esti-
mate policy relevant data on aspects of public health such
as healthy life expectancy and mortality [4].
The most commonly used SRH measure has a global or
current reference point (i.e. how would you rate your
health in general/at the present time?). A comparative
reference point is also often used to anchor the assess-
ment, such as comparing current health to previous
health (self-comparative), or same-aged peers (age-com-
parative). All these forms of the SRH item are in use in
health surveys around the world as an indicator of older
adults' years lived in good health [e.g. [3]]. Despite their
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extensive use, and the robust relationship between poor
ratings of SRH and major health outcomes, there is scant
research that has compared how these SRH measures
perform in older adult populations; in particular it has
not been established how the SRH measures compare in
their relationship with mortality.
In the few studies that have compared the association
between SRH items and mortality, mixed results have
been reported. Manderbacka, Kareholt, Martikainen and
Lundberg [5] found the predictive quality of global and
age-comparative SRH items was dependent on gender,
with the age-comparative item being a better predictor of
mortality for males than females in simultaneous models.
In contrast, Vuorisalmi, Lintonen and Jylhä [6] reported
both an age-comparative and global comparative item
was a stronger predictor of mortality for males than
females. Even less attention has been paid to the self-
comparative item, and the temporal reference point that
is used in the few studies has been broad (i.e. ranging
from 5 to 10 years previous). As the interval over which
participants gauge their health expands, so does the pos-
sibility that these retrospective reports may be erroneous.
For example, Bath [7] found that a global SRH item was
more robust in predicting mortality than a self-compara-
tive measure that asked older adults to compare their
present health to health five years previously. In a study
that compared a global, age-comparative and self-com-
parative (10 years previous) SRH items it was found that
the predictive quality of the self-comparative item
became less robust for males after longer follow up peri-
ods, whereas none of the SRH items were predictive of
mortality in adjusted models for females after 3 and 7.5
year follow-ups [8].
The inconsistent findings regarding the predictive qual-
ity of the different SRH items, and the effect that gender
may have on this SRH-mortality relationship, warrants
further investigation. It is also not clear the extent that
these SRH measures predict mortality independently of
other potential associated changes, as not all studies have
accounted for other known mortality risks, such as
demographic variables, health and health behaviours.
Furthermore, no study has accounted for the high corre-
lation between the SRH measures by simultaneously
modelling the three SRH measures together.
A further consideration is whether the SRH-mortality
relationship is constant over time. There is a growing
body of evidence that a dynamic evaluation of self-rated
health, that is, taking into account the potential time-
varying nature of SRH across time, may provide a more
authentic depiction of the relationship between subjec-
tive health assessments and mortality [9]. Cross-sectional
and longitudinal studies suggest SRH does not remain
stable across the lifespan [10-13]; therefore using a single
occasion measurement of SRH to predict mortality may
not take into account the biopsychosocial interactions of
health and the lifespan health trajectory [14,15]. The
advantage of modelling the relationship between time-
varying SRH ratings and mortality is that it enables the
modelling of time-varying predictors. Previous studies
have found that time-varying measures of Global SRH are
a superior predictor of mortality compared to a single
fixed measure [15-18]. However, no study to date has
investigated how dynamic changes in age-comparative or
self-comparative SRH may relate to mortality risk.
The aim of this study is to fill current gaps within the
literature regarding the sensitivity of time-varying SRH
measures with different reference points to predict mor-
tality in an older adult sample. The unique contributions
of the study are (1) the dynamic evaluation of the rela-
tionship between three time-varying SRH measures
(global, age-comparative and self-comparative) on mor-
tality risk, (2) the identification of the unique impact of
each SRH measure by controlling for time-dependent and
time-varying measures of biopsychosocial factors known
to increase mortality risk in older adults [15-17], and (3)
the comparison of the independent and concurrent rela-
tionship between the three SRH measures on mortality in
order to account for the correlation of these measures
and further determine their unique predictive quality.
While the literature suggests gender differences in the
relationship between SRH measures and mortality [e.g.
[5,7]], and age-group differences in SRH ratings [e.g.
[13,19]], it is not clear if men and women exhibit the same
association between SRH and mortality at different ages.
Therefore, interactions between SRH items and gender
and age-groups are also investigated in order to more
fully assess these dimensions of difference.
Methods
Sample
The Australian Longitudinal Study of Ageing (ALSA) has
been fully described elsewhere [20]. In brief, households
with residents over 70 years were identified from the
South Australian Electoral Database. The sample was
stratified by area, gender, and 5-year cohort groups (70-
74, 75-79, 80-84, and ≥ 85) [21]. Males were over-sampled
to ensure sufficient numbers in follow up. Of the 2,705
eligible residents 1,477 (55%) agreed to be interviewed.
Spouses (>65 years) and co-residents (>70 years) of the
sample were also asked to participate, which brought the
total number of participants at baseline to 2,087 commu-
nity dwelling and residential care individuals. The pat-
terns of health care utilization in the final sample were
found to be similar to that of the general Australian popu-
lation [20].
Data collection began in 1992. Baseline and waves 3 (24
months from baseline), 6 (96 months) and 7 (120 months)
data consisted of a comprehensive two-hour home inter-Sargent-Cox et al. BMC Geriatrics 2010, 10:18
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view including questions on demographic, health, medi-
cal, psychosocial, and physical status. Waves 2 (12
months from baseline), 4 (36 months), and 5 (60 months)
were conducted via short telephone interviews and
addressed changes in biopsychosocial factors since last
measurement period. Data from all seven waves were
included in the current study. Baseline ages ranged from
65 to 103 years of age (mean age = 78.14 years, SD = 6.68).
In the final wave of data collected the remaining 489 par-
ticipants were aged between 75 to 102 years (mean age =
84.94 years, SD = 4.90). Reasons for non-response at wave
7 were due to death (58.8% of the baseline participants),
participants unable to be contacted (2.0%), participants
who had moved out of scope of the study (2.3%), and
those that refused to be interviewed (13.5%). Table 1 dis-
plays the descriptive characteristics for the final sample
across all waves.
Measures
Mortality status
Mortality status was established through searches of offi-
cial death certificates conducted by the Epidemiological
Branch of the Department of Health in South Australia
and were confirmed by the South Australian Births,
Deaths and Marriage bureau [22]. Matching the ALSA
respondents to death information was conducted using
full name, date of birth, and last known address. During
the period from baseline to wave 7 1,228 deaths were
recorded (70.9% of sample; 58.3% males). As expected
there were significant differences between survivors and
non-survivors on predictor variables and covariates.
Compared to survivors, non-surviving respondents were
more likely to have poorer global (χ 2 (4) = 113.69, p <
.001), age- (χ2 (2) = 51.29, p < .001), and self-comparative
(χ2 (2) = 25.63, p < .001) SRH at baseline. They were also
more likely to be male (χ2 (1) = 55.65, p < .001), be older at
baseline (t(1731) = 22.49, p < .001), smoke (χ2 (2) = 12.54,
p = .002), have an income less than $12 000 (χ2 (4) = 32.05,
p < .001), less than 14 years of education (χ2 (1) = 8.58, p =
.003), be living in an institution (χ2 (1) = 48.15, p < .001),
and not have a partner (χ2 (1) = 39.49, p < .001). In addi-
tion non-survivors were in poorer health at baseline as
they were more likely to have more medical conditions
(t(1731) = 2.65, p  = .008), be on more medications
(t(1730) = 8.73, p < .001), have greater functional disabil-
ity (ADL's - t(1731) = 6.29, p < .001; IADL's - t(1731) =
8.27,  p  < .001), poorer cognitive functioning (MMSE;
t(1702) = -9.36, p < .001), and more depressive symptoms
(CES-D; t(1715) = 6.90, p < .001). Table 1 displays the
descriptive characteristics for the non-survivors at base-
line and the full sample across all waves.
Self-rated health (SRH)
Global SRH was measured with the question "How would
you rate your overall health at the present time?" (1-
'excellent' to 5-'poor'). Age-comparative SRH was mea-
sured in response to the question "Would you say your
health is better (1), about the same (2) or worse (3) than
most people your age?" Self-comparative SRH was
worded "Is your health now better (1), about the same (2)
or not as good (3) as it was 12 months ago?" Global and
self-comparative SRH was measured at all seven waves
whilst the age-comparative item was measured at base-
line, waves 3, 6, and 7. SRH ratings were reverse coded so
that the highest score was equivalent to the most positive
health rating.
Demographics
Demographic variables included gender, age, community
versus residential dwelling, partner status, annual
income, and number of years of education. The education
question asked participants how old they were when they
left school, with possible responses ranging from 1 =
never went to school, 2 = under fourteen years, 3 = four-
teen years, 4 = fifteen years, to 7 = eighteen or more
years. The education variable was dichotomised at the
median age category to reflect ≤ 14 years versus ≥ 15
years education [20,22].
Physical and functional health and medications
Participants were asked at baseline, wave 3, 6, and 7 if
they had been diagnosed and were currently suffering
from a heart condition, cancer, or diabetes. In addition
participants were shown a prompt card that listed
another 38 medical conditions including arthritis, diabe-
tes, and gallstones, and asked to indicate if they suffered
from these as well as list any other conditions they had.
The total number of conditions currently suffered was
summed to create a continuous aggregate score of num-
ber of conditions. At baseline, and waves 3 and 6 partici-
pants were asked to nominate, and show the interviewer
the container, for prescribed and non-prescribed media-
tions they were currently taking. Number of medications
was summed to reflect a continuous variable of total
number of medications for each respondent.
Functional status was assessed using the Activities for
Daily Living (ADL) and the Instrumental Activities of
Daily Living (IADL) measures [23] at all seven waves. The
ADL measures difficulties bathing, dressing, eating, using
the toilet, and getting around or away from home. IADL
questions include ten activities regarding housework,
meal preparation, money management and the use of
public transport. Scores are coded (0 = "no difficulty" and
1 = "difficulty") and summed so that higher scores indi-
cated greater functional disability.
Smoking status
Smoking Status measured current and past smoking of
cigarettes, pipe or cigars at baseline. The items were
coded to reflect (1) current smoker, (2) ex-smoker and (3)
never smoked.Sargent-Cox et al. BMC Geriatrics 2010, 10:18
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Table 1: Descriptive Statistics for all Waves, and Non-Survivors at Wave 1
Wave 1 Wave 2 Wave 3 Wave 4 Wave 5 Wave 6 Wave 7
Total Non-
Survivor
Total Total Total Total Total Total
N = 1733 N = 1228 N = 1522 N = 1451 N = 1301 N = 998 N = 740 N = 439
Global SRH (TV)
- poor 9.3% 12.2% 11.0% 6.7% 10.4% 10.1% 5.3% 6.9%
- fair 22.3% 25.7% 25.0% 25.0% 23.2% 25.5% 22.4% 26.8%
- good 30.0% 30.5% 29.7% 34.3% 31.6% 32.5% 34.7% 41.5%
- very good 29.5% 24.8% 26.2% 26.1% 27.4% 25.0% 27.7% 20.9%
- excellent 8.9% 6.8% 8.1% 7.9% 7.5% 7.0% 9.8% 3.9%
Age-Comp SRH 
(TV)
-worse 7.4% 9.1% 7.1% 4.0% 4.3%
- same 32.2% 34.1% 31.3% 36.7% 35.9%
- better 60.4% 56.8% 61.6% 59.3% 59.8%
Self-Comp SRH 
(TV)
-not as good 30.3% 35.4% 36.0% 39.3% 37.5% 43.8% 37.4% 41.6%
- same 56.5% 51.6% 55.4% 50.1% 55.6% 48.0% 52.6% 48.8%
- better 13.1% 12.9% 8.6% 10.6% 6.9% 8.2% 10.% 9.7%
Male 52.6% 58.3% 52.1% 50.1% 49.2% 46.0% 43.8% 38.7%
<$12 000 35.7% 39.5%
$12 001 - $20 
000
45.2% 43.6%
$20 001 - $30 
000
11.4% 9.6%
$30 001 - $50 
000
6.2% 5.7%
> $50 000 1.4% 1.5%
≥15 Years 
Education a
56.0% 41.4%
Partnered b (TV) 64.6% 59.9% 48.9% 19.4% 9.8%
Residential 
Care c (TV)
6.0% 9.4% 7.8% 14.2% 12.3%
Smoker 8.6% 10.0%
Ex Smoker 43.3% 44.2%
Non-Smoker 48.1% 45.8%
Mean 
(Standard 
Deviation)
Age (TV) 78.7
(6.72)
80.7
(6.37)
79.3
(6.60)
80.0
(6.53)
80.5
(6.40)
81.7
(6.08)
83.6
(5.59)
84.8
(4.77)
Conditions (TV) 2.86
(2.15)
2.94
(2.21)
4.03
(2.53)
4.03
(2.83)
5.18
(3.27)
Medications 
(TV)
3.26
(2.39)
3.58
(2.43)
3.99
(2.73)
3.89
(2.79)Sargent-Cox et al. BMC Geriatrics 2010, 10:18
http://www.biomedcentral.com/1471-2318/10/18
Page 5 of 12
Depressive symptoms
D e p r e s s i v e  s y m p t o m s  w e r e  m e a s u r e d  a t  b a s e l i n e  a n d
waves 3, 6 and 7, using the Centre for Epidemiology
Depression Scale (CES-D), a 20-item questionnaire
designed for use in community-based epidemiological
studies [24]. A four-point scale was used to assess how an
individual felt in the last week, with answers extending
from rarely or none of the time (0) to most of the time (3).
Summed scores ranged from 0 to 60 with a higher score
indicative of more depressive symptoms. The scale had a
high level of internal consistency with a Cronbach's alpha
coefficient of .85.
Cognitive functioning
Cognitive functioning was measured at baseline and
waves 3, 6 and 7, with the Mini-Mental State Examina-
tions scale [MMSE: [25]]. The scale assesses orientation
to place and time, attention and calculation, and memory
recall [20]. The MMSE has been shown to have satisfac-
tory reliability and construct validity and displays a high
degree of sensitivity for moderate to severe cognitive
impairment [26].
Statistical analysis
Participants with over 25% observable data missing (n =
354 (16.9%)) were removed from the data set [27] leaving
a final sample of 1,733 (52.6% males). This criteria was
used as Byrne [27] has shown that model and fit estimates
are comparable between a complete data set and one with
up to 25% data loss when a full information maximum
likelihood imputation method is used. Participants
removed from the data set were more likely to be male (χ2
(1) = 15.84, p < .001), older at baseline (t(2085) = 7.95, p <
.001), have a greater number of problems with ADL's
(t(2085) = 3.34, p = .001), and IADL's (t(2085) = 3.32, p =
.001), and be taking more medications (t(2085) = -4.51, p
< .001).
Of the final remaining sample 21.3% had < 5% missing
data over the seven waves, 14.9% had 6 to 10% missing,
6.8% had 11 to 15% missing, 13.9% had 16 to 20% missing,
and 43.1% had >21% missing. As expected, sensitivity
analysis revealed that there was a .96 probability (area
under the Receiver Operating Characteristic (ROC)
curve: Standard Error = .005) that a randomly chosen
participant in the final sample who had died over the fol-
low up period would have a greater percentage of missing
data compared to a randomly chosen survivor. The miss-
ing values for the remaining sample were imputed with
the maximum likelihood approach of the Expectation
Maximization (EM) algorithm method [28]. The EM
method uses all available data and alternates the iterative
algorithm between estimating missing values from
observed responses and parameter estimates and maxi-
mises the likelihood for the subsequent full data [29].
Cox regression models were used to analyse the effect
of time-varying predictors and covariates on mortality
risk (Singer & Willet, 2003). Number of years from base-
line interview until death or censorship was the measure
for time used in the models. The Cox Regression is a par-
tial likelihood method of estimation which takes into
account the number and rank order of deaths in the sam-
ple. Because of a 'conditioning argument' [[30]; p.520]
within the partial likelihood method no assumptions are
made regarding the shape of the baseline hazard function,
therefore only the effect of the predictors and covariates
are evaluated. The great advantage to using this Cox
Regression approach is that a model can be fitted regard-
less of the baseline hazard function complexity. Singer
and Willet [30] describe the probability of the event
(mortality) risk is modeled as:
where the time-invariant predictor or covariate in a
model is represented by X1i and the time-varying predic-
tor or covariate is represented by X2ij. h(tij)/h0(tj) repre-
sents an individual's (i) mortality hazard ratio (HR) at
time tj and is therefore a product of the baseline hazard
function h0, and the individuals true risk score at a given
time (i.e. the antilog of each raw coefficient - β1X1i + β2
X2ij). T o deal with the unbalanced data (i.e. not all vari-
In
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ADLs (TV) 0.41
(1.10)
0.52
(1.23)
0.55
(1.43)
1.15
(1.91)
1.10
(1.85)
1.20
(2.08)
1.28
(2.03)
0.84
(1.54)
IADLs (TV) 0.86
(1.58)
1.06
(1.74)
1.33
(2.13)
1.25
(1.45)
0.94
(1.70)
0.90
(1.55)
1.93
(1.84)
0.74
(1.46)
MMSE (TV) 26.90
(4.15)
26.24
(4.60)
27.33
(2.76)
28.06
(2.29)
25.89
(3.71)
Depressive 
Symptoms (TV)
8.41
(7.49)
9.26
(7.75)
8.36
(7.39)
8.84
(6.89)
5.60
(7.45)
Note: TV = Time-Varying Variables; ADL = Activities of Daily Living; IADL = Instrumental Activities of Daily Living; MMSE = Mini Mental State 
Examination Score. Reference Category a - ≤ 14 Years Education; b - Not Partnered; c - Community Dwelling.
Table 1: Descriptive Statistics for all Waves, and Non-Survivors at Wave 1 (Continued)Sargent-Cox et al. BMC Geriatrics 2010, 10:18
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ables are observed at every wave - see Table 1) we carried
forward the most recent value of each time-varying pre-
dictor to the next wave if it was missing at that wave [30].
Singer and Willet argue that this approach is particularly
appropriate to account for the shortfall of predictor infor-
mation for categorical data when there are complex pat-
terns of temporal variation of observations.
SRH items were treated as ordinal variables with the
reference category designated as the most positive rating
(i.e. 'excellent' for global; and 'better' for age-and self-
comparative). Covariates were computed to reflect time-
varying values over the observation periods with the
exception of the time-invariant covariates (gender, educa-
tion, income and smoking status). Income and smoking
status were included as categorical variables and there-
fore baseline measures were used for ease of interpreta-
tion. For time-invariant covariates the HR represents the
effect of a one-unit change in the related predictor on the
raw hazard of mortality over the 10 years of follow-up.
For the time-varying predictors and covariates, the HR
represents the weighted average of short-term mortality
risk across the 10 years follow-up (i.e. the mean of the
risks from baseline to first measurement period plus sec-
ond measurement to third measurement period and so
on) [31]. For the categorical predictors the interpretation
is essentially the same, except that the HR represents the
difference in the risk of mortality compared to the refer-
ence group.
The addition of gender and age-group interaction
terms into the ordinal models resulted in an additional 32
parameters. To ensure models remained parsimonious
[32] SRH items were not identified as categorical in the
separate interaction models allowing for an interaction
effect to be identified. A significant interaction term
r e s u l t e d  i n  a d j u s t e d  o r d i n a l  m o d e l s  r u n  b y  g r o u p  t o
ascertain group differences.
Results
Associations between SRH measures and mortality
Prior to the Cox regression models the relationship
between the three SRH measures was investigated. As
expected, correlations between the global, age-compara-
tive and self-comparative SRH measures across the seven
waves were all significant at p < .05. Correlations between
global and age-comparative SRH were moderate, ranging
from .271 (p < .000) at wave 7 to .471 (p < .001) at base-
line. Similar correlations were found between global and
self-comparative SRH, ranging from .278 (p  < .001) at
baseline to .475 (p < .001) at wave 4. Correlations were
smaller between age-comparative and self-comparative
SRH, ranging from .138 at wave 7 to .221 at baseline.
Table 2 shows the unadjusted associations between
SRH items and mortality as well as the net effects of SRH
items on mortality. 'Poor' global SRH increased the unad-
justed risk of mortality by 4.71 times, compared to 'excel-
lent' ratings (model 1). 'Worse' age-comparative SRH
increased mortality risk by 2 times compared to 'better'
ratings (model 2). 'Not as good' self-comparative ratings
increased the mortality risk by 1.23 times compared to
'better' ratings (model 3).
When global SRH was placed in the same models as
age-comparative (model 4) and self-comparative (model
5) SRH the relationship between 'worse' age-comparative
and 'not as good' self-comparative ratings and mortality
became non-significant. Model 6 revealed that 'worse'
age-comparative and 'not as good' self-comparative rat-
ings independently predicted mortality when placed in
the same model. In model 7, after accounting for shared
variance of all three SRH items, poor global SRH was
revealed as the strongest independent predictor of mor-
tality. These results confirm that the global SRH measure
accounts for the relationships between the comparative
SRH measures and mortality.
Table 3 shows the models adjusted for demographic
and health risk factors. In the independent models, after
accounting for other mortality risk factors, 'poor', 'fair' or
'good' global SRH ratings and 'worse' age-comparative
ratings over time indicate a significant increase in mortal-
ity risk for older adults compared to the most positive rat-
ings. In contrast, 'same' self-comparative ratings
significantly reduced the mortality risk compared to 'bet-
ter' over time. In the final full model, all three SRH items
are entered to account for overlap between these mea-
sures. This model shows that the relationship between
the three SRH measures and mortality remains relatively
unchanged from the independent models in Table 3. The
most notable difference is the reduction in hazard ratio
from 3.37 to 2.83 for 'poor' global SRH. This suggests that
a poor global rating reflects both age and self comparison
processes to some degree.
Gender and age by SRH item interactions
As described above separate models investigated gender
and age interactions with SRH. The gender by SRH inter-
action term was not significant (HR = 0.99, 95% CI: 0.98,
1.01). However, a significant age by SRH interaction term
was found (HR = 1.00, 95% CI: 1.00, 1.001). To investigate
the interaction effect separate adjusted models for each
age-group were conducted (see Table 4). Age-groups
were categorised into young-old (65 to 74 years), old-old
(75 to 84 years) and oldest-old (85+ years) at baseline, as
defined in the gerontological literature [33].
The young-old age-group model revealed that "poor"
global and "worse" age-comparative ratings significantly
predicted mortality. For the old-old adults age-compara-
tive and self-comparative SRH did not independently pre-
dict mortality . Similarly , only 'poor' global ratings were
found to significantly predict mortality for the oldest-oldSargent-Cox et al. BMC Geriatrics 2010, 10:18
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age-group. Averaging 'same' self-comparative health
resulted in a significant reduction in mortality risk for
young-old and oldest-old adults compared to 'better' rat-
ings over time.
Discussion
Our results indicate that the three SRH items do not have
comparable relationships with mortality. These results
build on previous findings that SRH measures with differ-
ent reference points are not interchangeable measures of
subjective health for older adults [5,34]. To our knowl-
edge this is the first time the predictive nature of three
commonly used SRH items have been compared over
time in a dynamic evaluation model. This comparison
revealed that, overall, global SRH was the strongest pre-
dictor of mortality when taking into account the time-
varying nature of the ratings across time, whilst the weak-
est association was with the self-comparative item.
These findings are contrary to some previous studies
that have found that an age-comparative SRH item is a
more robust predictor of mortality than a global item for
males in a similar age-group [5], or that the three SRH
items had similar predictive qualities (55 to 85 year old
sample) [8]. However for most previous studies the SRH-
mortality associations have been modelled separately for
gender [e.g. [5-8]]. The contrasting methodology that was
used in the current study revealed non-significant inter-
action terms for gender in the models, indicating that the
Table 2: Hazard Ratios (and 95% Confidence Intervals) Comparing Time-Varying Self-Rated Health (SRH) Models 
Predicting Mortality (N = 1733)
M o d e l  1M o d e l  2M o d e l  3M o d e l  4M o d e l  5M o d e l  6M o d e l  7
Global SRH Age-
comparative 
SRH
Self-
Comparative 
SRH
Global & Age-
Comparative
Global & Self-
Comparative
Age-& Self-
Comparative
All SRH
Global SRH
Poora 4.71***
(3.48, 6.40)
4.79***
(3.50,6.56)
4.01***
(2.92, 5.52)
4.09*** (2.95, 
5.68)
Faira 2.31***
(1.71, 3.11)
2.42***
(1.79, 3.27)
2.06***
(1.52, 2.80)
2.16*** (1.59, 
2.95)
Gooda 1.54***
(1.14, 2.07)
1.59**
(1.78, 2.15)
1.46*
(1.08, 1.97)
1.51** (1.11, 
2.04)
Very Gooda 1.13
(0.82, 1.54)
1.15
(0.84, 1.57)
1.10
(0.81, 1.52)
1.12 (0.82, 1.54)
Age-
Comparative 
SRH
Worse b 2.00***
(1.75, 2.52)
1.08
(0.88, 1.31)
1.73***
(1.44, 2.08)
1.07 (0.88, 1.31)
Same b 1.05
(0.93, 1.18)
0.85*
(0.75, 0.96)
0.99
(0.88, 1.13)
0.85** (0.75, 
0.97)
Self-
Comparative 
SRH
Not as Good c 1.27*
(1.05, 1.54)
0.85
(0.78, 1.16)
1.21*
(1.00, 1.47)
0.96 (0.78, 1.17)
Same c 0.67***
(0.56, 0.81)
0.74**
(0.61, 0.91)
0.68***
(0.55, 0.82)
0.75** (0.61, 
0.91)
Null-2LL 16548.63 16548.63 16548.63 16548.63 16548.63 16548.63
-2LL 16264.89 16436.01 16509.75 16485.01 16264.89 16239.88
AIC 16312.89 16474.01 16557.75 16533.01 16312.89 16287.88
BIC 16342.62 16503.74 16587.48 16562.74 16342.62 16317.61
Note: a - Reference Category is "Excellent"; b & c "Better". LL = Log Likelihood. ***p < .001; **p < .01; *p < .05.Sargent-Cox et al. BMC Geriatrics 2010, 10:18
http://www.biomedcentral.com/1471-2318/10/18
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Table 3: Hazard Ratios and 95% Confidence Intervals for Adjusted Self-Rated Health Models Predicting Mortality; the 
Australian Longitudinal Study of Ageing, 1992 - 2004 (N = 1733)
Independent SRH Models Concurrent SRH
Model
Global SRH Age-Comparative
SRH
Self-Comparative
SRH
Full Model
Global (TV)
- poora 3.37*** 2.44, 4.65 2.83*** 2.02, 3.98
- faira 1.94*** 1.42, 2.65 1.80*** 1.31, 2.48
- gooda 1.47* 1.08, 2.00 1.43* 1.05, 1.95
- very gooda 1.21 0.88, 1.66 1.19 0.87, 1.64
Age-Comp (TV)
- worseb 1.94*** 1.58, 2.38 1.41** 1.14, 1.74
- sameb 1.13 0.99, 1.29 1.02 0.89, 1.16
Self-Comp (TV)
- not as goodc 1.09 0.90, 1.32 0.91 0.74, 1.12
- samec 0.72** 0.59, 0.88 0.75** 0.61, 0.93
Male 1.61*** 1.42, 1.84 1.65*** 1.45, 1.87 1.64*** 1.44, 1.87 1.62*** 1.42, 1.84
<$12 000d 0.74 0.47, 1.18 0.76 0.48, 1.22 0.73 0.45, 1.16 0.78 0.49, 1.25
$12 001 - $20 000d 1.02 0.64, 1.62 1.01 0.64, 1.61 0.97 0.61, 1.55 1.05 0.66, 1.68
$20 001 - $30 000d 0.85 0.52, 1.38 0.83 0.51, 1.36 0.80 0.48, 1.30 0.89 0.55, 1.46
$30 001 - $50 000d 1.11 0.67, 1.85 1.10 0.66, 1.83 1.04 0.62, 1.73 1.14 0.68, 1.91
≥15 Years Education e 0.93 0.83, 1.05 0.92 0.82, 1.04 0.92 0.82, 1.04 0.93 0.82, 1.04
Partnered (TV) f 0.20*** 0.17, 0.25 0.21*** 0.17, 0.25 0.21*** 0.17, 0.26 0.20*** 0.17, 0.25
Residential Care (TV) g 0.84 0.72, 0.99 0.82* 0.71, 0.96 0.83* 0.71, 0.98 0.86 0.74, 1.00
Age (TV) 1.07*** 1.06, 1.08 1.07*** 1.06, 1.08 1.07*** 1.06, 1.08 1.07*** 1.06, 1.08
Smokerh 1.61*** 1.31, 1.98 1.58*** 1.28, 1.94 1.71*** 1.40, 2.11 1.62*** 1.32, 2.00
Ex Smokerh 1.13 0.99, 1.29 1.12 0.98, 1.28 1.14 1.00, 1.31 1.12 0.98, 1.28
Number of Conditions 
(TV)
0.96*** 0.94, 0.98 0.96** 0.94, 0.99 0.96** 0.94, 0.99 0.95*** 0.93, 0.98
Number of 
Medications (TV)
1.04** 1.01, 1.06 1.05*** 1.03, 1.07 1.05*** 1.02, 1.07 1.04** 1.01, 1.06
ADL (TV) 1.08*** 1.05, 1.11 1.11*** 1.08, 1.14 1.11*** 1.08, 1.14 1.08*** 1.05, 1.11
IADL (TV) 1.01 0.98, 1.04 1.01 0.98, 1.04 1.00 0.98, 1.03 1.00 0.98, 1.03
MMSE (TV) 0.98* 0.97, 1.00 0.99* 0.97, 1.00 0.98** 0.97, 0.99 0.98* 0.97, 1.00
Depressive Symptoms 
(TV)
1.00 0.99, 1.01 1.00 0.99, 1.01 1.01 1.00, 1.01 1.00 0.99, 1.00
Null-2LL 16548.62 16548.62 16548.62 16548.62
-2LL 15367.35 15452.53 15446.04 15346.16
AIC 15415.35 15500.53 15494.04 15394.16
BIC 15445.08 15530.26 15523.77 15423.89
Note: TV = Time-Varying Variables; ADL = Activities of Daily Living; IADL = Instrumental Activities of Daily Living; MMSE = Mini Mental State 
Examination Score; LL = log likelihood; AIC = Akaike Information Criterion; BIC = Bayesian Information Criteria. Reference Category a - 
"Excellent"; b & c - "Better"; d -Income at baseline of $50 000 or more per year;e- ≤ 14 Years Education;f - Not Partnered;g - Community Dwelling;h 
-Non-smoker at baseline. ***p < .001; **p < .01; *p < .05.Sargent-Cox et al. BMC Geriatrics 2010, 10:18
http://www.biomedcentral.com/1471-2318/10/18
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relationship between the different SRH measures and
mortality was not significantly different for males and
females,. Hence separate models for men and women
were not justified.
Furthermore, our findings expand the literature
because the comparison of the three SRH items was
investigated through a dynamic model of SRH and mor-
tality, using time-varying SRH ratings to predict mortal-
ity rather than ratings at a single point in time. By
modelling the mortality hazard using time-varying pre-
dictors and covariates we assessed the cumulative short-
term effects of SRH ratings on mortality over a 10 year
follow-up period. While well-suited to the global SRH
data, the findings indicate that this dynamic evaluation
Table 4: Hazard Ratios and 95% Confidence Intervals for Concurrent SRH Adjusted Age-Group Models Predicting 
Mortality; the Australian Longitudinal Study of Ageing, 1992 - 2004
Young-Old
N = 583
Old-Old
N = 790
Oldest-Old
N = 405
Global (TV)
- poora 2.98** 1.18, 8.54 3.88*** 2.32, 6.48 1.97* 1.13, 3.44
- faira 2.24 0.95, 5.27 2.30** 1.41, 3.74 1.29 0.77, 2.15
- gooda 1.90 0.85, 4.26 1.82* 1.14, 2.90 1.01 0.61, 1.67
- very gooda 1.43 0.62, 3.26 1.40 0.86, 2.28 1.06 0.63, 1.78
Age-Comp (TV)
- worseb 2.57*** 1.60, 4.15 1.17 0.86, 2.28 1.05 0.65, 1.71
- sameb 1.16 0.83, 1.26 0.91 0.75, 1.10 1.06 0.84, 1.35
Self-Comp (TV)
- not as goodc 0.80 0.51, 1.26 1.03 0.77, 1.37 0.76 0.51, 1.21
- samec 0.52** 0.32, 0.83 0.89 0.67, 1.19 0.65* 0.44, 0.96
Male 2.52*** 1.85, 3.42 1.54*** 1.28, 1.85 1.48** 1.15, 1.91
<$12 000d 1.15 0.56, 5.15 0.77 0.42, 1.39 0.32* 0.13, 0.82
$12 001 - $20 000d 1.48 0.34, 6.52 1.19 0.66, 2.16 0.33* 0.13, 0.85
$20 001 - $30 000d 1.17 0.26, 5.24 1.13 0.60, 2.13 0.24** 0.09, 0.65
$30 001 - $50 000d 1.90 0.40, 9.01 1.41 0.73, 2.72 0.37 0.13, 1.04
≥ 15 Years Education e 0.81 0.60, 1.08 0.98 0.82, 1.16 0.09 0.66, 1.03
Partnered (TV) f 0.15*** 0.10, 0.22 0.17*** 0.13, 0.23 0.34*** 0.21, 0.56
Residential Care (TV) g 1.50 0.81, 2.78 0.89 0.71, 1.12 0.79 0.62, 1.01
Smokerh 2.16*** 1.43, 3.25 1.60** 1.18, 2.16 1.08 0.67, 1.74
Ex Smokerh 1.23 0.88, 1.72 1.09 0.91, 1.32 0.96 0.75, 1.27
Number of Conditions (TV) 0.95 0.89, 1.00 0.97 0.94, 1.00 0.94** 0.89, 0.98
Number of Medications (TV) 1.04 0.98, 1.11 1.02 0.99, 1.06 1.05* 1.01, 1.09
ADL (TV) 1.06 0.97, 1.16 1.09*** 1.05, 1.14 1.07** 1.02, 1.12
IADL (TV) 1.00 0.92, 1.05 1.00 0.95, 1.04 1.02 0.97, 1.06
MMSE (TV) 1.00 0.96, 1.05 0.98 0.96, 1.01 0.97** 0.95, 0.99
Depressive Symptoms (TV) 0.99 0.97, 1.01 0.99* 0.98, 1.00 1.00 0.99, 1.02
Null-2LL 2550.95 7141.28 3979.88
-2LL 2248.52 6745.06 3858.00
AIC 2598.95 7189.00 4027.88
BIC 2616.49 7210.54 4042.46
Note: TV = Time-Varying Variables; ADL = Activities of Daily Living; IADL = Instrumental Activities of Daily Living; MMSE = Mini Mental State 
Examination Score; LL = log likelihood; AIC = Akaike Information Criterion; BIC = Bayesian Information Criteria. Reference Category a - 
"Excellent"; b & c - "Better"; d -Income at baseline of $50 000 or more per year;e- ≤ 14 Years Education;f - Not Partnered;g - Community Dwelling;h 
-Non-smoker at baseline. ***p < .001; **p < .01; *p < .05.Sargent-Cox et al. BMC Geriatrics 2010, 10:18
http://www.biomedcentral.com/1471-2318/10/18
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model may not be as suitable for investigating compara-
tive SRH items' association with mortality. In support of
this premise additional analysis (not shown here) com-
pared the mortality risk for single measurement SRH rat-
ings (baseline and most recent observation prior to
death). These results revealed that the most recent obser-
vation of poor self-comparative SRH (rating health as
"not as good" as 12 months prior) held a similar associa-
tion with mortality risk (HR = 1.67; 95% CI = 1.38-2.01)
as the most recent 'poor' global SRH rating (HR = 1.66;
95% CI = 1.18-2.34) after adjusting for all SRH measures
and other mortality risk factors. In contrast, rating health
as worse than others their own age did not significantly
predict mortality in the long term (baseline model - HR =
1.14;  95% CI = 0.89-1.46), or on a shorter follow-up
period (most-recent observation model - HR = 1.03; 95%
CI = 0.83-1.28). These results tentatively suggest that age-
comparative SRH is not a good indicator of mortality risk
for older adults, whereas considering health to have
declined in the past 12 months (self-comparative SRH)
ma y be as good a short term indicator of mortality as
poor global SRH.
The difference in predictive quality of these SRH mea-
sures is most likely due to the fundamental nature of
anchoring the health evaluation to a particular reference
point, such as peers or own past health. For example, the
age-comparative item may enhance health assessments
due to a self-protective 'social downgrading' process [35],
whereas the forced temporal aspect of the self-compara-
tive item elicits more negative ratings as it makes recent
negative changes in health more salient [36]. Etiologically
speaking, self-perceived temporal decline in health could
be argued to be a good indicator of imminent mortality
risk, as the further analysis above has demonstrated.
However, with advanced health decline older adults may
perceive that their health cannot get any worse, thus they
may begin to rate their health as 'the same' as previous,
placing an inherent limitation to the self-comparative
item for providing unique mortality information over
time. This limitation of the self-comparative SRH mea-
sure may also explain our seemingly counterintuitive
findings that 'same' self-comparative ratings are protec-
tive of mortality risk compared to 'better' ratings. For
example, an individual who rates their health as 'better'
than the previous year could be reflecting on their experi-
e n c e  o f  r e c e n t  h e a l t h  i s s u e s  t h a t  m a y  s u b s e q u e n t l y
increase mortality risk. The contrast between the propor-
tion of the current sample who rated their health as "bet-
ter than others their own age" and "not as good as twelve
months ago", along with the small to medium correlations
found between the SRH measures, supports the notion
that the reference point invokes specific comparison pro-
cesses which can bias health assessments [14,37], making
them less predictive of mortality over time.
Idler and Benyamini [14] and Jylhä [38] argue that the
robust SRH-mortality relationship found in global SRH is
most likely due to complex, dynamic human judgements
that include contextual evaluation frameworks where
past and current health is considered along with future
health expectations. In the few studies that have com-
pared the determinants of global and comparative SRH
items, the global measure has been found to be the most
inclusive measure of subjective health in terms of its
associations with other factors of health [37,39]. For
example, Eriksson et al. [39] found that physical, func-
tional and mental health, health behaviours, and psycho-
social factors (such as social support), held significantly
stronger associations with global SRH compared to an
age-comparative measure. Similarly, the global measure
has previously been shown to be the most comprehensive
SRH item for the ALSA sample used here [40]. Taken
together, these findings suggest that the strong associa-
tion observed between global SRH and mortality is due to
the global measure reflecting an all-encompassing evalu-
ation of health compared to the other SRH items.
In the current study the utility of the SRH items to pre-
dict mortality was dependent on age. In particular, the
two comparative measures did not provide unique infor-
mation of mortality risk in adults over 75 years of age. It
has been argued that the age-comparative item is not
appropriate to use in older populations, or samples with a
large age range, due to its sensitivity to age [6,34,38]. The
current findings support this notion of age-sensitivity and
extend it to the self-comparative item. Further research is
needed to clarify whether these comparison effects
extend to other age groups or are merely cohort effects.
Whilst the focus of the current study was on the impact
of the varying SRH measures on mortality, and the major-
ity of the covariate relationships with mortality are as
expected, there are findings in the models that are note
worthy. For example, we found a significant protective
effect for number of medical conditions. We suggest that
the counterintuitive relationship between number of
medical conditions and mortality found here are a prod-
uct of the large number of non-life threatening conditions
t h a t  w e r e  i n c l u d e d ,  s u c h  a s  c a t a r a c t s ,  g o u t ,  h e r n i a ,
ingrown toenails, and migraines. The conditions included
in the aggregate variable were not weighted here for life-
threat, as previous research has suggested that this does
not necessarily improve model fit [41], however the com-
bination of stage of disease and comorbidity was found by
these authors to increase mortality risk. Together with
the current findings it is suggested that future research is
needed to ascertain the best way to measure and weight
comorbidity in relation to mortality risk.
The major strength of our study is that the large
amount of longitudinal data (up to seven waves spanning
12 years) allowed for comprehensive health models to beSargent-Cox et al. BMC Geriatrics 2010, 10:18
http://www.biomedcentral.com/1471-2318/10/18
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tested in a time-varying approach. Furthermore, the mor-
tality relationship of each SRH item was established by
directly comparing the items whilst accounting for shared
variance with other SRH items and health covariates. A
limitation of the data set is the unbalanced data collection
(i.e. not all measures were observed at each wave) and the
different modes of data collection (face-to-face versus
telephone interview). Whilst, previous research has sup-
ported the reliability of telephone interviewing and the
strong correlation between this mode with face-to-face
interviewing in established samples [e.g. [42,43]], the
unbalanced data may require care in the interpretation of
results. Singer and Willet [30] argue that the method of
imputing the time-varying predictors when they are not
observed, by carrying forward the most recent value (as
was used here, see Statistical Analysis section), is most
likely to result in a conservative estimate. It should also be
noted that the small number of oldest-old adults at base-
line remaining in the wave 6 and 7 samples could limit
our findings, as small sample sizes may result in reduc-
tion of statistical power to detect significant effects [29].
Baseline selection effects of this age group must also be
taken into account [44], along with possible sample attri-
tion due to causes other than mortality. For example, the
significant differences in characteristics of the excluded
participants (due to missing data, see Statistical Analysis
section above) suggest a possible bias as the oldest-old,
males, and those with increased functional difficulties
and number of medications were less likely to be included
in the final sample. However, the finding that 'poor' global
SRH predicted mortality for the oldest-old age group in
the adjusted models, as did being male and having
increased ADL's, suggests our results are more likely to be
an underestimation of effects. Therefore the relationship
between time-varying SRH and mortality risk may in fact
be stronger than is indicated here.
Conclusions
In conclusion, global, age-comparative and self-compara-
tive SRH items embody unique, age-sensitive, associa-
tions with mortality over time. Researchers should
exercise caution when pooling or harmonising SRH items
as they are not comparable measures of health. Future
research investigating the potential for time-varying, and
even change in, SRH measures to predict other major
health outcomes, such as functional disability and health
care utilisation, may extend the application of SRH items
for indicators of population health.
The age sensitivity of the comparative SRH measures
suggests they should be used with caution in older adult
populations, particularly if used for predicting mortality.
Furthermore, the usefulness of tracking age- and self-
comparative measures to predict mortality is limited by
the anchoring of the evaluation to the reference point. In
contrast, 'poor' global is a robust predictor of mortality
across age groups over time, indicating that this is the
most reliable measure of self-perceived health for older
adults.
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